GL1X · GenesisL1 explorer

Research workbench

Human PARP10 (ARTD10), catalytic fragment in complex with parp inhibitor veliparib

Analyse Human PARP10 (ARTD10), catalytic fragment in complex with parp inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5LX6
Type
protein
Length
380 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 10
EC
2.4.2.30
UniProt
Q53GL7
Ligands
78P
Pockets
3 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 10 (EC 2.4.2.30)protein19126% helix, 28% strandQ53GL7
BPoly [ADP-ribose] polymerase 10 (EC 2.4.2.30)protein18926% helix, 29% strandQ53GL7

Ligands and binding sites

  • 78P · (2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16560.770.826278P
23270.720.8535empty
33150.630.793078P

Interfaces

1 interface between chains.

  • A–B · 937 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 5LX6 · Human PARP10 (ARTD10), catalytic fragment in complex with PARP inhibitor Veliparib · the same entry in another collection · chain A against A, TM-score 1.00
  • Q53GL7 · AlphaFold monomer V2.0 prediction for protein mono-ADP- ribosyltransferase PARP10 (Q53GL7) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.